5,052
Views
14
CrossRef citations to date
0
Altmetric
Review Article

The role of mTOR in age-related diseases

, ORCID Icon & ORCID Icon
Pages 1678-1692 | Received 19 Jan 2021, Accepted 18 Jun 2021, Published online: 26 Jul 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Sheng Hu, Yijie Zhang, Chenming Qiu & Ying Li. (2023) RGS10 inhibits proliferation and migration of pulmonary arterial smooth muscle cell in pulmonary hypertension via AKT/mTORC1 signaling. Clinical and Experimental Hypertension 45:1.
Read now

Articles from other publishers (13)

Ashley Payne, Equar Taka, Getinet M. Adinew & Karam F. A. Soliman. (2023) Molecular Mechanisms of the Anti-Inflammatory Effects of Epigallocatechin 3-Gallate (EGCG) in LPS-Activated BV-2 Microglia Cells. Brain Sciences 13:4, pages 632.
Crossref
Sanjeev K. Ganesh & C. Subathra Devi. (2023) Molecular and therapeutic insights of rapamycin: a multi-faceted drug from Streptomyces hygroscopicus. Molecular Biology Reports 50:4, pages 3815-3833.
Crossref
Victoria Kaupp, KingaG Blecharz-Lang, Christina Dilling, Patrick Meybohm & Malgorzata Burek. (2023) Protocadherin gamma C3: a new player in regulating vascular barrier function. Neural Regeneration Research 18:1, pages 68.
Crossref
Zofia Chrienova, David Rysanek, Patrik Oleksak, Dorota Stary, Marek Bajda, Milan Reinis, Romana Mikyskova, Ondrej Novotny, Rudolf Andrys, Adam Skarka, Pavla Vasicova, Josef Novak, Martin Valis, Kamil Kuca, Zdenek Hodny & Eugenie Nepovimova. (2022) Discovery of small molecule mechanistic target of rapamycin inhibitors as anti-aging and anti-cancer therapeutics. Frontiers in Aging Neuroscience 14.
Crossref
Mahmoud Al-Azab, Mohammed Safi, Elina Idiiatullina, Fadhl Al-Shaebi & Mohamed Y. Zaky. (2022) Aging of mesenchymal stem cell: machinery, markers, and strategies of fighting. Cellular & Molecular Biology Letters 27:1.
Crossref
Fernanda D. Botelho, Eugenie Nepovimova, Kuca Kamil & Tanos C. C. Franca. (2022) Virtual screening and molecular dynamic study of potential new binders to mTOR. Journal of Molecular Modeling 28:10.
Crossref
Patrik Oleksak, Eugenie Nepovimova, Zofia Chrienova, Kamil Musilek, Jiri Patocka & Kamil Kuca. (2022) Contemporary mTOR inhibitor scaffolds to diseases breakdown: A patent review (2015–2021). European Journal of Medicinal Chemistry 238, pages 114498.
Crossref
Soheila Montazersaheb, Ali Ehsani, Ezzatollah Fathi & Raheleh Farahzadi. (2022) Cellular and Molecular Mechanisms Involved in Hematopoietic Stem Cell Aging as a Clinical Prospect. Oxidative Medicine and Cellular Longevity 2022, pages 1-13.
Crossref
Julian M. Carosi, Célia Fourrier, Julien Bensalem & Timothy J. Sargeant. (2021) The mTOR–lysosome axis at the centre of ageing. FEBS Open Bio 12:4, pages 739-757.
Crossref
Hua-Chuan Zheng, Hang Xue, Yu-Zi Jin, Hua-Mao Jiang & Zheng-Guo Cui. (2022) The Oncogenic Effects, Pathways, and Target Molecules of JC Polyoma Virus T Antigen in Cancer Cells. Frontiers in Oncology 12.
Crossref
Lanlan Tang, Yu Fu, Jiarun Song, Taibing Hu, Kun Li & Zhi Li. (2022) mTOR inhibition by TAK‐228 is effective against growth, survival and angiogenesis in preclinical retinoblastoma models. Pharmacology Research & Perspectives 10:1.
Crossref
Karen Schindler. (2021) Inhibition of BIN2 extends reproductive lifespan. Nature Aging 1:11, pages 977-979.
Crossref
Marti Cadena Sandoval, Alexander Martin Heberle, Ulrike Rehbein, Cecilia Barile, José Miguel Ramos Pittol & Kathrin Thedieck. (2021) mTORC1 Crosstalk With Stress Granules in Aging and Age-Related Diseases. Frontiers in Aging 2.
Crossref